Ninety-day trial period change concerning for manufacturers

Manufacturing

The changes to the 90-day trial period announced today by the Government will present additional challenges for medium sized manufacturers to finding the right staff they need, adding to the already critical skill shortage issues which hold back growth of the sector.

“The 90-day trial periods have made it easier for manufacturers to bring on staff to fill skill shortages, knowing they have the ability to take a risk on a new worker. The proposed change will make it harder for companies to fill vacancies – the last thing they need right now.” says Dieter Adam, CE, The Manufacturers’ Network.

“At least we are still going to have the 90-day trial periods for companies under 20 employees, as for businesses of this size the risk and investment in bringing on a new staff member is very high. But the Government should have left these trial periods alone altogether.” he states.

“If the Government is serious about growing the economy, it should focus its efforts on working with industry in addressing the short and longer-term skill shortages that are crippling the high-value manufacturing industry and many other sectors.  These skill shortages are often in the area of highly skilled and experienced trade’s workers, with level 5 and 6 qualifications.” says Adam.

 

Related Articles
Industrial scale metal additive manufacturing: EOS M4 ONYX
 EOS who specialise in laser powder bed fusion (LPBF) additive manufacturing (AM), has unveiled the EOS M4 ONYX at Formnext 2025. “At EOS, our customers have always been at the heart of every...
Unleashed unlocks low-cost MRP for small manufacturers
Inventory management software company, Unleashed, has released a new product giving smaller manufacturers the Material Requirements Planning (MRP) abilities of companies many times their size – at a...
NZ Nutrient extraction tech modernises US$60bn traditional Chinese medicine sector
A nutrient extraction technology developed by Kiwi scientists is set to transform the US$60 billion global Traditional Chinese Medicine (TCM) sector, modernising production methods that have remained...